Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 02/24

Trade details

Type: Insider sale
Amount: $156,229.38
Shares · price: 10,034 sh · $15.57 a share
Held after: 442,883 sh
Stock: KalVista Pharmaceuticals KALV
Person: Benjamin L. PalleikoCEO
Trade date: 26/02/23
Filed: 26/02/24
Days to filing: 1 days

Sold 2.2% of holdings

Share of holding sold: 2.2%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/24~03/25

Benjamin L. Palleiko's recent trades

Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09

Benjamin L. Palleiko, CEO — sold $156.2K of KalVista Pharmaceuticals KALV · 2.2% of holdings | Whalegun